FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3081818689> ?p ?o ?g. }

• W3081818689 endingPage "1813" @default.
• W3081818689 startingPage "1807" @default.
• W3081818689 abstract "Background: Surgeons have hesitated to use steroids in patients undergoing posterior spinal fusion because of the risk of wound complications. The literature has supported the use of postoperative steroids in other areas of orthopaedics on the basis of more rapid recovery and improved postoperative pain control. We hypothesized that a short course of postoperative dexamethasone following posterior spinal fusion for the treatment of adolescent idiopathic scoliosis (AIS) would decrease opioid usage without increasing wound-healing problems. Methods: Consecutive patients undergoing posterior spinal fusion for the treatment of AIS from 2015 to 2018 at a single hospital were included. A review of demographic characteristics, curve characteristics, surgical data, and postoperative clinic notes was performed. Opioid usage was determined by converting all postoperative opioids given into morphine milligram equivalents (MME). Results: Sixty-five patients underwent posterior spinal fusion for the treatment of AIS without postoperative steroids (the NS group), and 48 patients were managed with 3 doses of postoperative steroids (the WS group) (median, 8.0 mg/dose). There was no difference between the groups in terms of curve magnitude, number of vertebrae fused, or estimated blood loss. There was a 39.6% decrease in total MME used and a 29.5% decrease in weight-based MME used in the group receiving postoperative steroids (82.0 mg [1.29 mg/kg] in the NS group versus 49.5 mg [0.91 mg/kg] in the WS group]; p < 0.001). This difference persisted after accounting for gabapentin, ketorolac, and diazepam usage; surgical time; curve size; levels fused; and number of osteotomies (median decrease, 0.756 mg/kg [95% CI, 0.307 to 1.205 mg/kg]; p = 0.001). Three patients in the NS group (4.6%) and 4 patients in the WS group (8.3%) developed wound dehiscence requiring wound care (p = 0.53). One patient in the NS group required surgical debridement for the treatment of an infection. Patients in the WS group were more likely to walk at the time of the initial physical therapy evaluation (60.4% versus 35.4%; p = 0.013). Conclusions: A short course of postoperative steroids after posterior spinal fusion was associated with a 40% decrease in the use of opioids, with no increase in wound complications. Surgeons may consider the use of perioperative steroids in an effort to decrease the use of postoperative opioids following posterior spinal fusion for the treatment of AIS. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence." @default.
• W3081818689 created "2020-09-08" @default.
• W3081818689 creator A5007595974 @default.
• W3081818689 creator A5008339280 @default.
• W3081818689 creator A5026747634 @default.
• W3081818689 creator A5031717648 @default.
• W3081818689 creator A5039129759 @default.
• W3081818689 creator A5043939696 @default.
• W3081818689 date "2020-08-19" @default.
• W3081818689 modified "2023-10-18" @default.
• W3081818689 title "Postoperative Dexamethasone Following Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis" @default.
• W3081818689 cites W1013576710 @default.
• W3081818689 cites W1597070806 @default.
• W3081818689 cites W1965329150 @default.
• W3081818689 cites W2013980575 @default.
• W3081818689 cites W2014772207 @default.
• W3081818689 cites W2016202131 @default.
• W3081818689 cites W2042420460 @default.
• W3081818689 cites W2049966052 @default.
• W3081818689 cites W2054221193 @default.
• W3081818689 cites W2111366073 @default.
• W3081818689 cites W2150691073 @default.
• W3081818689 cites W2164803788 @default.
• W3081818689 cites W2283506723 @default.
• W3081818689 cites W2333819395 @default.
• W3081818689 cites W2342427515 @default.
• W3081818689 cites W2439818010 @default.
• W3081818689 cites W2467181706 @default.
• W3081818689 cites W2515207118 @default.
• W3081818689 cites W2519862268 @default.
• W3081818689 cites W2605677253 @default.
• W3081818689 cites W2606534928 @default.
• W3081818689 cites W2610807320 @default.
• W3081818689 cites W2610936380 @default.
• W3081818689 cites W2717900862 @default.
• W3081818689 cites W2754754279 @default.
• W3081818689 cites W2771964366 @default.
• W3081818689 cites W2788463873 @default.
• W3081818689 cites W2800910095 @default.
• W3081818689 cites W2810059497 @default.
• W3081818689 cites W2886168474 @default.
• W3081818689 cites W2889901597 @default.
• W3081818689 cites W2894768322 @default.
• W3081818689 cites W2894795675 @default.
• W3081818689 cites W2901759141 @default.
• W3081818689 cites W2919260319 @default.
• W3081818689 cites W2967179128 @default.
• W3081818689 cites W2971708887 @default.
• W3081818689 cites W2979072937 @default.
• W3081818689 cites W2990204920 @default.
• W3081818689 doi "https://doi.org/10.2106/jbjs.20.00259" @default.
• W3081818689 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33086348" @default.
• W3081818689 hasPublicationYear "2020" @default.
• W3081818689 type Work @default.
• W3081818689 sameAs 3081818689 @default.
• W3081818689 citedByCount "11" @default.
• W3081818689 countsByYear W30818186892020 @default.
• W3081818689 countsByYear W30818186892021 @default.
• W3081818689 countsByYear W30818186892022 @default.
• W3081818689 countsByYear W30818186892023 @default.
• W3081818689 crossrefType "journal-article" @default.
• W3081818689 hasAuthorship W3081818689A5007595974 @default.
• W3081818689 hasAuthorship W3081818689A5008339280 @default.
• W3081818689 hasAuthorship W3081818689A5026747634 @default.
• W3081818689 hasAuthorship W3081818689A5031717648 @default.
• W3081818689 hasAuthorship W3081818689A5039129759 @default.
• W3081818689 hasAuthorship W3081818689A5043939696 @default.
• W3081818689 hasConcept C126322002 @default.
• W3081818689 hasConcept C141071460 @default.
• W3081818689 hasConcept C2777389121 @default.
• W3081818689 hasConcept C2778446825 @default.
• W3081818689 hasConcept C2780375110 @default.
• W3081818689 hasConcept C2780401358 @default.
• W3081818689 hasConcept C2780820201 @default.
• W3081818689 hasConcept C2780955175 @default.
• W3081818689 hasConcept C2993634128 @default.
• W3081818689 hasConcept C42219234 @default.
• W3081818689 hasConcept C68312169 @default.
• W3081818689 hasConcept C71924100 @default.
• W3081818689 hasConceptScore W3081818689C126322002 @default.
• W3081818689 hasConceptScore W3081818689C141071460 @default.
• W3081818689 hasConceptScore W3081818689C2777389121 @default.
• W3081818689 hasConceptScore W3081818689C2778446825 @default.
• W3081818689 hasConceptScore W3081818689C2780375110 @default.
• W3081818689 hasConceptScore W3081818689C2780401358 @default.
• W3081818689 hasConceptScore W3081818689C2780820201 @default.
• W3081818689 hasConceptScore W3081818689C2780955175 @default.
• W3081818689 hasConceptScore W3081818689C2993634128 @default.
• W3081818689 hasConceptScore W3081818689C42219234 @default.
• W3081818689 hasConceptScore W3081818689C68312169 @default.
• W3081818689 hasConceptScore W3081818689C71924100 @default.
• W3081818689 hasIssue "20" @default.
• W3081818689 hasLocation W30818186891 @default.
• W3081818689 hasOpenAccess W3081818689 @default.
• W3081818689 hasPrimaryLocation W30818186891 @default.
• W3081818689 hasRelatedWork W2018644495 @default.
• W3081818689 hasRelatedWork W2032512577 @default.
• W3081818689 hasRelatedWork W2035724723 @default.

• next